Showing results (771-780 of 901) with videos related to
Sort By:
Pageof 91
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group studyK Kelly, J J Crowley, P A Bunn, et al.Plos One|November 20, 2025
Concern for severe COVID-19 disease during the initial two years of pandemic in a rural South African community: A population-based studyArmstrong Dzomba, Palesa Mataboge, Nicole K Kelly, et al.Journal of Cancer Survivorship : Research and Practice|February 19, 2026
Symptom burden among long-term survivors of young adult cancer: a report from the Project Milestones cohortDavid R Freyer, Marcie D Haydon, Rebecca K Kelly, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2005
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancerMichael J Morris, Carlos Cordon-Cardo, William K Kelly, et al.Molecular and Cellular Endocrinology|December 22, 2015
Biological activity and in vivo half-life of pro-activin A in male ratsKatharine E Johnson, Yogeshwar Makanji, Peter Temple-Smith, et al.Urology|April 1, 1997
Assessment of hormone refractory prostate cancerD Newling, S D Fosså, L Andersson, et al.Vaccine|August 25, 2024
Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March - December 2021Nadja A Vielot, Nicole K Kelly, Christina Ludema, et al.Transfusion|August 5, 2022
Hormones, age, and sex affect platelet responsiveness in vitroJamie B Hadley, Marguerite R Kelher, Julia R Coleman, et al.Surgical Neurology International|June 8, 2022
Myeloid sarcoma of the skull base: A case report and systematic literature reviewPrazwal Athukuri, A Basit Khan, Ron Gadot, et al.European Journal of Cancer (Oxford, England : 1990)|April 5, 2011
An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumoursRebecca K Kelly, Dian L Olson, Yaping Sun, et al.Pageof 91